Harvest Fund Management Co. Ltd Increases Stake in AstraZeneca PLC

Harvest Fund Management Co. Ltd increased its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 27.8% during the fourth quarter, as detailed in the firm’s latest 13F filing with the Securities and Exchange Commission. After acquiring an additional 7,447 shares during this period, Harvest Fund now holds a total of 34,270 shares in the company.

As of the recent filing, Harvest Fund Management Co. Ltd's investments in AstraZeneca were valued at approximately $2,245,000.

Activity of Other Institutional Investors

Other large investors have also been actively adjusting their stakes in AstraZeneca. For instance, Cibc World Markets Corp increased its holdings by 1.1%, now owning 12,901 shares worth $845,000 after buying an additional 142 shares. Similarly, Diversify Wealth Management LLC raised its stake by 3.6%, owning 4,402 shares valued at $295,000 after purchasing 153 more shares.

Veery Capital LLC enhanced its investment by 4.7%, holding 3,503 shares worth $230,000 after acquiring 157 additional shares. Moreover, Rehmann Capital Advisory Group reported a 1.8% increase in their holdings during the third quarter, now owning 10,027 shares valued at $788,000.

Lastly, Hardy Reed LLC increased its investment by 5.9%, now holding 3,182 shares worth $248,000 after acquiring 178 shares in the last quarter. Overall, institutional investors currently own about 20.35% of AstraZeneca's stock.

Analysts Upgrades and Ratings

AstraZeneca has recently been featured in several analyst reports. UBS Group upgraded the stock from a "neutral" to a "buy" rating on February 13th, while Morgan Stanley initiated coverage, setting an investment, shares, AstraZeneca